Guardian Pharmacy Services (GRDN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
11 May, 2026Leadership and management
Co-founders have deep industry experience, including prior successful exits and leadership roles in pharmacy and healthcare sectors.
Investor relations led by a seasoned equity markets professional with over 30 years of experience.
Market opportunity and positioning
Focused on the $7 billion assisted living facility (ALF) and memory care pharmacy market, serving over 1 million residents.
Holds a 13% nationwide ALF market share, serving over 140,000 ALF residents and 205,000 total residents.
Operates 54 pharmacy locations with high adoption rates (~90%) in ALFs.
Market is highly fragmented, offering significant room for expansion.
Business model and competitive advantages
Service-led, tech-enabled model with local service and centralized support, driving improved accuracy and adherence.
Proprietary technology ecosystem includes robotics, eMAR integration, and clinical intelligence platforms.
High barriers to entry due to regulatory complexity, scale requirements, and need for specialized talent.
Latest events from Guardian Pharmacy Services
- Expanding assisted living pharmacy services through tech, analytics, and strategic acquisitions.GRDN
Stephens Annual Investment Conference8 Jul 2026 - Strong 2024 growth and expansion, with 2025 outlook positive despite IPO-related net loss.GRDN
Q4 20248 Jul 2026 - Tech-enabled growth and legislative advocacy position the company for continued market expansion.GRDN
Stephens 26th Annual Investment Conference | NASH20248 Jul 2026 - Strong growth, stable margins, and expanding market share position the company for continued success.GRDN
Raymond James & Associates’ 46th Annual Institutional Investors Conference30 Jun 2026 - Strong quarter, raised guidance, and poised for growth in the fragmented assisted living pharmacy market.GRDN
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue and net income rose, prompting higher full-year EBITDA guidance.GRDN
Q1 20266 May 2026 - Capturing 13% of the ALF pharmacy market, growth is driven by tech, service, and disciplined expansion.GRDN
44th Annual J.P. Morgan Healthcare Conference12 Apr 2026 - Annual meeting to vote on directors, executive pay, say-on-pay frequency, and auditor ratification.GRDN
Proxy filing26 Mar 2026 - Annual meeting to vote on directors, executive pay, auditor, and governance changes.GRDN
Proxy filing26 Mar 2026